Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03092882 · ClinicalTrials.gov registry record · NA
Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1c
A NA study, sponsored by Evidation Health.
- Completed
- Registry status
- NA
- Development phase
- 607
- Enrollment target
NCT03092882 is a NA study that has completed, run by Evidation Health. The registered enrollment target is 607 participants.
The verdict
NCT03092882, a NA study, has completed, sponsored by Evidation Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 607 participants
- Enrollment target
Study Summary
The Digital Self-Management Program for Medicare Advantage Members with Type 2 Diabetes - Impact on A1c trial is a 26-week long, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Digital Self-Management Program on A1c levels for individuals with uncontrolled Type 2 diabetes.
Interventions
- BEHAVIORAL Diabetes Self-Management Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 607 participants |
| Start Date | 2017-03-03 |
| Est. Completion | 2018-02-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03092882
The ClinicalTrials.gov registry entry for NCT03092882 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 607 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Evidation Health, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diabetes Self-Management Program is the first listed.
NCT03092882 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03092882 about?
NCT03092882 is a clinical study titled "Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1c". The Digital Self-Management Program for Medicare Advantage Members with Type 2 Diabetes - Impact on A1c trial is a 26-week long, prospective, intent-to-treat, 2-arm randomized controlled trial that aims to evaluate the impact of the Digital Self-Management Program on A1c levels for individuals with ...
What is the current status of trial NCT03092882?
This trial is currently completed. It is a NA study. The enrollment target is 607 participants. The study started on 2017-03-03. Estimated completion is 2018-02-07.
What interventions are being tested in trial NCT03092882?
The interventions under investigation include: Diabetes Self-Management Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03092882?
This trial is sponsored by Evidation Health, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.